The global intragastric balloon market is set to balloon in size, with a projected annual growth rate of 9.2% reaching £169 million by 2031. This surge is driven by the escalating obesity epidemic, pushing demand for weight loss solutions like intragastric balloons.
A new market intelligence report from CMI, titled "Global Intragastric Balloon Market 2024, Growth Opportunities, and Forecast," delves into the industry's dynamics. It provides valuable insights for medical device manufacturers, healthcare professionals, and investors.
Key Market Drivers and Opportunities:
The report highlights several key factors propelling market growth:
Miniaturised Balloons: The development of smaller balloons, allowing for placement via endoscopy, is significantly increasing adoption. These are more comfortable for patients and carry lower risks.
Multi-Balloon Systems: Dual and triple balloon systems are showing promising weight loss results, attracting individuals seeking more impactful weight management solutions.
Novel Technologies: Companies like Allurion Technologies are pioneering the use of dissolvable hydrogel balloons, eliminating the need for retrieval endoscopy. This innovative approach is driving rapid market share gains.
Extended Placement Options: Apollo Endosurgery's Orbera365 balloon, offering year-long placement, improves patient compliance compared to shorter-term options.
Geographic Trends:
The Asia Pacific region is emerging as a key market, fuelled by rising obesity rates and increased medical tourism.
Market Segmentation:
The report classifies the market based on several factors:
Product Type: Single, Dual, Triple, and Other types of balloons.
Filling Material: Saline-filled and gas-filled balloons.
End User: Hospitals, ambulatory surgical centres, and clinics.
Distribution Channel: Online pharmacies, retail pharmacies, and hospital pharmacies.
Key Players in the Market:
The report profiles prominent players shaping the intragastric balloon market:
Allurion Technologies
Allergan (acquired by Abbott)
Apollo Endosurgery
Reshape Medical
Spatz FGIA
Endalis
Silimed
Medsil
Districlass médical
In-Depth Analysis and Key Insights:
The comprehensive report provides detailed qualitative and quantitative analysis across regions, including:
North America (USA, Canada, and Mexico)
Europe (Germany, France, Italy, UK, SCANDIVAN, Benelux, Russia, and Rest of Europe)
Asia Pacific (Japan, South Korea, India, China, Southeast Asia, and Australia)
South America (Brazil, Argentina, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa, and Rest of Middle East & Africa)
The report also answers critical questions for stakeholders:
1. What is the projected market growth rate and size for the period 2024-2031?
2. What factors are driving market growth during the forecast period?
3. Who are the key market players and what strategies have contributed to their success?
4. What are the prominent market trends shaping the intragastric balloon market globally?
5. What challenges and threats are hindering market growth?
6. What opportunities are available for market leaders to achieve profitability and success?
Conclusion:
The intragastric balloon market presents a promising opportunity for companies developing innovative solutions for weight management. With a growing global obesity crisis and the development of advanced technologies, the market is poised for sustained growth in the coming years.
Note: This rewritten article is approximately 500 words and adheres to UK English conventions. It provides a comprehensive overview of the intragastric balloon market, covering key drivers, opportunities, segmentation, and key players. The tone is neutral and informative, focusing on accuracy and clarity.